Abstract
Alrestatin, an aldose reductase inhibitor, was administered orally to 10 normal men. Its effect on basal plasma glucose, insulin and glucagon levels and on the response of glucose, insulin and glucagon to an oral alanine load was assessed and compared to that of a placebo. There was a significant suppression of both the mean basal insulin level and the mean insulin response to alanine in the group pretreated with alrestatin as compared to the placebo group (p < 0.05 at 0 and 60min). Glucagon levels rose slightly in both groups but tended to be lower in the alrestatin-treated subjects, and blood sugar levels fell slightly. There was a significant inverse correlation between the mean insulin and glucose levels in individual subjects. The possible significance and mechanisms of insulin suppression are discussed.
References
Dvomik D., Simard-Duquesne V., Kraml M., Sestanj K., Gabbay K.H., Kinoshito J.H., Varma S., Merow L.O. Polyol accumulation of galactoseamic and diabetic rats: control by an aldose reductase inhibitor. Science 182: 1146, 1973.
Kobric M., Lippmann W. Effect of alrestatin sodium on glucose-stimulated insulin secretion in the fasted anaesthetized rat. Horm Metab. Res. 10: 495, 1978.
Lippmann W, Kobric M. Effect of alrestatin on arginine-induced secretion of glucagon and insulin in the rat. Horm. Metab. Res. 10: 263, 1978.
Gabbey K.H., Tze W.J., Inhibition of glucose induced insulin release by aldose reductase inhibitors. Proc. Natl. Acad. Sci. USA 69: 1435, 1972.
Welborn T.S., Fraser T.R. The double antibody immunoassay of insulin. Diabetologia 1: 211, 1965.
Kuku S.F., Zeidler A., Emmanouel D.S., Katz A.L., Rubenstein A.H., Levin N.W., Tello A. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes. J. Clin. Endocrinol. Metab. 42: 173, 1976.
Gabbay K.H., Spack N., Loo S., Hirsch H.J., Ackil A.A. Aldose reductase inhibition: studies with alrestatin. Metabolism 28 (Suppl. 1): 471, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Distiller, L.A., Joffe, B.I., Sandler, M. et al. The effect of alrestatin on alanine-stimulated release of insulin and glucagon in man. J Endocrinol Invest 4, 115–117 (1981). https://doi.org/10.1007/BF03349428
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349428